Sosei Heptares is a biotechnology company that specializes in drug discovery and development, focusing on G protein-coupled receptors (GPCRs). The company utilizes its proprietary StaR (Stabilized Affinity Receptor) technology to create stabilizing variants of GPCRs for the purpose of developing novel therapeutic agents. Sosei Heptares collaborates with pharmaceutical partners to advance its drug candidates and also has internal programs aimed at addressing various disease areas.